Li Zhou
2Department Of Hematology, No.197, Ruijin Er Road
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Treatment-free remission in chronic myeloid leukaemia patients with accelerated phase or tyrosine kinase inhibitor therapy failure.
Journal: British journal of haematology
Published: June 14, 2025
Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation.
Journal: Haematologica
Published: May 15, 2025
Anlotinib exerts an anti-T-cell acute lymphoblastic leukemia effect in vitro and in vivo.
Journal: Cellular signalling
Published: March 19, 2023
Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.
Journal: Frontiers in psychiatry
Published: March 12, 2021
Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study.
Journal: Annals of hematology
Published: January 17, 2021
Quinacrine Depletes BCR-ABL and Suppresses Ph-Positive Leukemia Cells.
Journal: Cancer investigation
Published: July 13, 2019
WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia.
Journal: Cancer cell international
Published: December 05, 2018
USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia.
Journal: Signal transduction and targeted therapy
Published: June 26, 2018
Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition.
Journal: Cell death & disease
Published: January 24, 2018
Effects of Quercetin on Chronic Myeloid Leukemia Cell Line Resistant to Imatinib and Its Mechanism
Journal: Zhongguo shi yan xue ye xue za zhi
Published: April 28, 2017
Last Updated: 09/26/2026